Versor Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Buy |
17,857
+2,357
| +15% | +$184K | 0.25% | 87 |
|
2025
Q1 | $1.12M | Buy |
+15,500
| New | +$1.12M | 0.18% | 167 |
|
2024
Q4 | – | Sell |
-4,455
| Closed | -$294K | – | 822 |
|
2024
Q3 | $294K | Buy |
4,455
+2,255
| +103% | +$149K | 0.05% | 595 |
|
2024
Q2 | $203K | Sell |
2,200
-4,300
| -66% | -$397K | 0.04% | 658 |
|
2024
Q1 | $621K | Buy |
+6,500
| New | +$621K | 0.13% | 269 |
|
2023
Q4 | – | Sell |
-4,496
| Closed | -$311K | – | 753 |
|
2023
Q3 | $311K | Buy |
4,496
+2,043
| +83% | +$142K | 0.06% | 476 |
|
2023
Q2 | $231K | Sell |
2,453
-7,122
| -74% | -$672K | 0.04% | 518 |
|
2023
Q1 | $792K | Buy |
+9,575
| New | +$792K | 0.1% | 177 |
|
2022
Q2 | – | Sell |
-1,773
| Closed | -$209K | – | 834 |
|
2022
Q1 | $209K | Buy |
+1,773
| New | +$209K | 0.01% | 573 |
|
2020
Q3 | – | Sell |
-8,448
| Closed | -$584K | – | 304 |
|
2020
Q2 | $584K | Sell |
8,448
-6,849
| -45% | -$473K | 0.06% | 71 |
|
2020
Q1 | $962K | Sell |
15,297
-3,303
| -18% | -$208K | 0.06% | 55 |
|
2019
Q4 | $1.45M | Buy |
+18,600
| New | +$1.45M | 0.07% | 95 |
|